Skip to main content
Clinical Trials/NCT05314556
NCT05314556
Completed
N/A

Effectiveness of Group Psychotherapy in Patients With Narcolepsy Type 1

Cantonal Hospital of St. Gallen1 site in 1 country10 target enrollmentAugust 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Narcolepsy Type 1
Sponsor
Cantonal Hospital of St. Gallen
Enrollment
10
Locations
1
Primary Endpoint
Fatigue (Severity)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of this pilot study is to test the benefit of behavior therapy-oriented, method-integrated psychotherapy in an outpatient group setting in patients with narcolepsy type 1. Therefore we collect and evaluate initial data on its effectiveness on the disease in terms of specific symptomatology, emotion regulation, health-related quality of life, and disease processing/acceptance.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
December 31, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nicolas Germann

Principal Investigator

Cantonal Hospital of St. Gallen

Eligibility Criteria

Inclusion Criteria

  • Diagnosed narcolepsy type 1 according to AASM, examined by an experienced sleep physician including history, clinical examination, polysomnographic examination (PSG) with a multiple sleep latency test (MSLT), possibly also including determination of HLA DQB1 \* 062 and orexin A / hypocretin 1
  • Age between 18 and 65 years
  • Signed informed consent
  • Exclusion of other clinically relevant organic sleep disorders by means of polysomnography (AHI\>10/h)

Exclusion Criteria

  • Presence of severe psychiatric comorbidity
  • Other psychotherapy during the study period
  • Change of medication used for narcolepsy therapy shortly before the start and during the study period including follow-up measurement. In this case, patients may still complete group therapy, but the data will not be included in the analysis.

Outcomes

Primary Outcomes

Fatigue (Severity)

Time Frame: Week 0-24

German version of the questionnaire "Fatigue Severity Scale" (FSS; Valko et al., 2008)

Daytime sleepiness

Time Frame: Week 0, Week 6, Week 12, Week 24

German version of the questionnaire "Epworth Sleepiness Scale" (ESS; Johns, 1991)

Sleep quality

Time Frame: Week 0-24

German version of the questionnaire "Pittsburgh Sleep Quality Index" (PSQI; Buysse et al., 2008)

Emotion regulation

Time Frame: Week 0-24

German questionnaire "Fragebogen zur Erhebung der Emotionsregulation bei Erwachsenen" (FEEL-E; Grob et al., 2014)

Secondary Outcomes

  • Disease processing, acceptance & coping(Week 0, Week 6, Week 12, Week 24)
  • Anxiety & depression(Week 0, Week 6, Week 12, Week 24)
  • Health-related quality of life (HRQOL)(Week 0-24)

Study Sites (1)

Loading locations...

Similar Trials